These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26040420)

  • 1. PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner.
    Lindblad O; Kazi JU; Rönnstrand L; Sun J
    Cell Mol Life Sci; 2015 Nov; 72(22):4399-407. PubMed ID: 26040420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.
    Sun J; Mohlin S; Lundby A; Kazi JU; Hellman U; Påhlman S; Olsen JV; Rönnstrand L
    Oncogene; 2014 Nov; 33(46):5360-9. PubMed ID: 24213578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant.
    Chian R; Young S; Danilkovitch-Miagkova A; Rönnstrand L; Leonard E; Ferrao P; Ashman L; Linnekin D
    Blood; 2001 Sep; 98(5):1365-73. PubMed ID: 11520784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
    Pedersen M; Rönnstrand L; Sun J
    Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessity of tyrosine 719 and phosphatidylinositol 3'-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation.
    Hashimoto K; Matsumura I; Tsujimura T; Kim DK; Ogihara H; Ikeda H; Ueda S; Mizuki M; Sugahara H; Shibayama H; Kitamura Y; Kanakura Y
    Blood; 2003 Feb; 101(3):1094-102. PubMed ID: 12393643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.
    Sun J; Pedersen M; Rönnstrand L
    J Biol Chem; 2009 Apr; 284(17):11039-47. PubMed ID: 19265199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for the adaptor protein Grb10 in the activation of Akt.
    Jahn T; Seipel P; Urschel S; Peschel C; Duyster J
    Mol Cell Biol; 2002 Feb; 22(4):979-91. PubMed ID: 11809791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.
    Agarwal S; Kazi JU; Mohlin S; Påhlman S; Rönnstrand L
    Oncogene; 2015 Aug; 34(35):4581-90. PubMed ID: 25435369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of c-KIT expression level and phosphatidylinositol 3-kinase activation in survival and proliferative responses of early myeloid cells.
    Young SM; Cambareri AC; Ashman LK
    Cell Signal; 2006 May; 18(5):608-20. PubMed ID: 16002264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit.
    Sun J; Pedersen M; Rönnstrand L
    J Biol Chem; 2008 Oct; 283(41):27444-27451. PubMed ID: 18697750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib.
    Gleixner KV; Mayerhofer M; Cerny-Reiterer S; Hörmann G; Rix U; Bennett KL; Hadzijusufovic E; Meyer RA; Pickl WF; Gotlib J; Horny HP; Reiter A; Mitterbauer-Hohendanner G; Superti-Furga G; Valent P
    Blood; 2011 Aug; 118(7):1885-98. PubMed ID: 21680801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis.
    Munugalavadla V; Sims EC; Borneo J; Chan RJ; Kapur R
    Blood; 2007 Sep; 110(5):1612-20. PubMed ID: 17483298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid rafts are required for Kit survival and proliferation signals.
    Jahn T; Leifheit E; Gooch S; Sindhu S; Weinberg K
    Blood; 2007 Sep; 110(6):1739-47. PubMed ID: 17554062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT
    Phung B; Kazi JU; Lundby A; Bergsteinsdottir K; Sun J; Goding CR; Jönsson G; Olsen JV; Steingrímsson E; Rönnstrand L
    Mol Cancer Res; 2017 Sep; 15(9):1265-1274. PubMed ID: 28584020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D816V mutation in the KIT gene activation loop has greater cell-proliferative and anti-apoptotic ability than N822K mutation in core-binding factor acute myeloid leukemia.
    Omori I; Yamaguchi H; Miyake K; Miyake N; Kitano T; Inokuchi K
    Exp Hematol; 2017 Aug; 52():56-64.e4. PubMed ID: 28506695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570.
    Chaix A; Arcangeli ML; Lopez S; Voisset E; Yang Y; Vita M; Letard S; Audebert S; Finetti P; Birnbaum D; Bertucci F; Aurrand-Lions M; Dubreuil P; De Sepulveda P
    Oncogene; 2014 Feb; 33(7):872-81. PubMed ID: 23416972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of KIT Oncogenic Signaling in Leukemia with Antibodies Targeting KIT Membrane Proximal Domain 5.
    Le Gall M; Crépin R; Neiveyans M; Auclair C; Fan Y; Zhou Y; Marks JD; Pèlegrin A; Poul MA
    Mol Cancer Ther; 2015 Nov; 14(11):2595-605. PubMed ID: 26358753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors.
    Caenepeel S; Renshaw-Gegg L; Baher A; Bush TL; Baron W; Juan T; Manoukian R; Tasker AS; Polverino A; Hughes PE
    J Exp Clin Cancer Res; 2010 Jul; 29(1):96. PubMed ID: 20633291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors.
    Lee AW; States DJ
    Mol Cell Biol; 2000 Sep; 20(18):6779-98. PubMed ID: 10958675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.
    Timokhina I; Kissel H; Stella G; Besmer P
    EMBO J; 1998 Nov; 17(21):6250-62. PubMed ID: 9799234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.